2021
DOI: 10.3390/biom11020312
|View full text |Cite
|
Sign up to set email alerts
|

Substrate-Dependent Sensitivity of SIRT1 to Nicotinamide Inhibition

Abstract: SIRT1 is the most extensively studied human sirtuin with a broad spectrum of endogenous targets. It has been implicated in the regulation of a myriad of cellular events, such as gene transcription, mitochondria biogenesis, insulin secretion as well as glucose and lipid metabolism. From a mechanistic perspective, nicotinamide (NAM), a byproduct of a sirtuin-catalyzed reaction, reverses a reaction intermediate to regenerate NAD+ through “base exchange”, leading to the inhibition of the forward deacetylation. NAM… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 63 publications
0
3
0
Order By: Relevance
“…Furthermore, gastric acids are not expelled into the duodenum after DJB, which increases the pH of duodenal content. The deacetylation activity of SIRT1 is pH-dependent, and higher pH attenuates the inhibition of SIRT1 by nicotinamide[ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, gastric acids are not expelled into the duodenum after DJB, which increases the pH of duodenal content. The deacetylation activity of SIRT1 is pH-dependent, and higher pH attenuates the inhibition of SIRT1 by nicotinamide[ 36 ].…”
Section: Discussionmentioning
confidence: 99%
“…Unlike NMN and NR, NAM can inhibit sirtuins, a class of proteins linked to NAD+ benefits. [90,91]. Additionally, NAM conversion to NAD+ has inherent limitations.…”
Section: Efficacy and Therapeutic Applications Of Nad+ Boosting Strat...mentioning
confidence: 99%
“…2) and measured the RNA levels by RT-qPCR. We treated cells with trichostatin A (TSA), an inhibitor of class I, II, IV, histone deacetylases (HDACs) [57], nicotinamide (NAM) [58], an inhibitor of class III HDACs (sirtuins), or PJ34, an inhibitor of Poly (ADPribose) polymerase-1 (PARP-1) [59][60][61]. These treatments were performed either in presence or absence of 5-Aza-dC (Aza), an inhibitor of DNA methylation [57].…”
Section: The Frg2 Promoter Is Activated By Inhibition Of Histone Acet...mentioning
confidence: 99%